 |
|
Women's Cancer Outcome Improved by Surgical Evaluation
February 13, 2009SAN ANTONIO, Texas - Many women scheduled to undergo hysterectomy for pre-cancerous cell changes actually need a more comprehensive surgery, something they should discuss with a gynecologic oncologist, say researchers at the University of Alabama at Birmingham (UAB).
If seen by a specialist, it should be recommended they undergo a procedure that focuses on lymph nodes and other organs not involved in a traditional hysterectomy, said Warner Huh, M.D., a researcher at the UAB Comprehensive Cancer Center.
The finding was presented at the Society of Gynecologic Oncologists' 2009 Annual Meeting on Women's Cancer in San Antonio.
"Given the high rate of endometrial cancer, these data strongly suggest all women who have abnormal bleeding and a diagnosis of pre-cancerous lesions of the uterus should be evaluated by a gynecologic oncologist," Huh said.
Huh and his research team analyzed medical records of more than 3,322 patients treated at seven community hospitals across Alabama from 1999 to 2008. They specifically looked women diagnosed with pre-cancerous changes called complex atypical hyperplasia (CAH).
Of patients who underwent a traditional hysterectomy, about half were found to have invasive endometrial cancer after their procedure. That means too many hysterectomy patients should've had a more comprehensive cancer surgery, something a gynecologist oncologist is trained to do, Huh said.
To avoid unwanted outcomes, women diagnosed with CAH should be referred to a gynecologic oncologist for evaluation, he said.
University of Alabama at Birmingham
"Given the high rate of endometrial cancer, these data strongly suggest all women who have abnormal bleeding and a diagnosis of pre-cancerous lesions of the uterus should be evaluated by a gynecologic oncologist," Huh said.
Huh and his research team analyzed medical records of more than 3,322 patients treated at seven community hospitals across Alabama from 1999 to 2008. They specifically looked women diagnosed with pre-cancerous changes called complex atypical hyperplasia (CAH).
Of patients who underwent a traditional hysterectomy, about half were found to have invasive endometrial cancer after their procedure. That means too many hysterectomy patients should've had a more comprehensive cancer surgery, something a gynecologist oncologist is trained to do, Huh said.
To avoid unwanted outcomes, women diagnosed with CAH should be referred to a gynecologic oncologist for evaluation, he said.
University of Alabama at Birmingham
Gynecologic Oncologist Current Events and Gynecologic Oncologist News RSSAddition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
No differences in survival or neonatal outcomes in pregnancy-associated colorectal cancer
In one of the first studies to examine maternal and newborn health risks and colorectal cancer, UC Davis researchers have found that women diagnosed with the disease during or shortly after their pregnancies have the same survival as women who have the disease and are not pregnant.
Minimizing obesity's impact on ovarian cancer survival
Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian cancer survival. A study by researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center found ovarian cancer survival rates are the same for obese and non-obese women if their chemotherapy doses are closely matched to individual weight.
Malignant tumor or benign cyst?
The results of a study presented today at the Society of Gynecologic Oncology's 39th Annual Meeting on Women's Cancer offer a promising development on the path toward better management of ovarian cancer.
Women with AIDS face cervical cancer threat
According to a report issued last week by UNAIDS, access to antiretroviral therapy is beginning to reduce AIDS mortality worldwide.
New genetic marker characterizes aggressiveness of cancer cells
Levels of a small non-coding RNA molecule called let-7 appear to define different stages of cancer better than some of the "classical" markers for tumor progression.
Mayo Clinic finds aggressive surgery best option for advanced-stage ovarian cancer patients
Mayo Clinic Cancer Center researchers report aggressive surgical removal of as much cancer as possible throughout the abdomen in ovarian cancer patients is the best option for most women.
More Gynecologic Oncologist Current Events and Gynecologic Oncologist News Articles
 |
Chemotherapy of Gynecologic Cancers: Society of Gynecologic Oncologists Handbook by Stephen C Rubin (Editor) Univ. of Pennsylvania, Philadelphia. Pocket-sized handbook reviews the advances in chemotherapy for gynecologic cancers. Discusses the development of cytotoxic drugs, the refinement of new combination chemotherapy regimens, and the introduction of new methods to minimizing and treating drug toxicity. Includes new data on hematologic growth factors. Previous edition: c1996. Softcover. |
 |
Chemotherapy Of Gynecologic Cancers Society Of Gynecologic Oncologists Handbook by Lippincott Williams & Wilkins Chemotherapy of Gynecologic Cancers Society of Gynecologic Oncologists Handbook : Chemotherapy of Gynecologic Cancers Society of Gynecologic Oncologists Handbook Pub Date: November 2003 Product Type: Print Author/s: Stephen C Rubin MD Prepared under the aegis of the Society of Gynecologic Oncologists, this handbook contains all the information clinicians need to care for patients undergoing chemotherapy for gynecologic cancers. Organized to provide quick access to critical information, the book outlines specific treatment regimens for gynecologic cancers by site and stage and offers detailed guidelines on choosing the best regimen for each patient, preparing patients for chemotherapy, and ameliorating side effects and complications. This edition includes all new drugs... |
 |
Pocket Guide for Women and Cancer by Giselle J. Moore (Author), Lois A. Almadrones (Author), Beth Colvin Huff (Author), Lynn M. Gossfeld (Author), Giselle J. Moore (Editor), Lois A. Almadrones (Editor), Beth Colvin Huff (Editor), Lynn M. Gossfeld (Editor), Joann Huang Eriksson (Editor), Society of Gynecologic Nurse Oncologists (Editor) Pocket Guide for Women and Cancer highlights the unique nursing care issues associated with the screening, diagnosis, and treatment of gynecologic nursing oncology. Using a concise, accessible format, these plans of care provide a quick and easy reference for all practice settings, including inpatient, outpatient, and home care. Organized by body system, the plans feature both collaborative problems and nursing diagnoses to reflect current practice. This resource can be used independently or as a clinical companion to the comprehensive text Women and Cancer: A Gynecologic Oncology Nursing Perspective. |
|
Chemotherapy of Gynecologic Cancers: Society of Gynecologic Oncologists Handbook by Stephen C. Rubin (Author) | |
|
Practical Procedures for the Gynecological Oncologist by A. P. M. Heintz (Editor), D. G. Allen (Editor) Academic Hospital Utrecht, The Netherlands. Text providing procedures and techniques necessary to the resident and practitioner in gynecologic oncology. Includes practical surgical aspects which are helpful in daily practice. Halftone line drawings and photographs. DNLM: Genital Neoplasms, Female--surgery. |
| © 2009 BrightSurf.com |